Amnon Peled

Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.

eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA.

Part of Thermo Fisher Scientific, Inc., Ethrog Biotechnologies Ltd is an Israeli company that develops products and technologies for electrophoretic separation of macromolecules. The company is based in Ness Ziona, Israel. The company was founded by Shmuel Cabilly. Ethrog Biotechnologies was acquired by Invitrogen Corp. on June 21, 2000 for $14.18 million.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

msystems Ltd. develops, manufactures, and markets flash data storage solutions for the digital consumer electronics markets. Its products include mDrive and various USB-enabled devices, mDOC embedded flash drives for mobile handsets and consumer electronics devices. The company was founded in 1989 and is located in Kfar Saba, Israel.

Ofakim Hi-Tech Ventures Ltd. (Ofakim Hi-Tech Ventures) is a venture capital subsidiary of Capital Point Ltd. founded in 1991. The firm is headquartered in Ofakim, Israel.

Polyheal Ltd. provides wound healing products. The company was founded by Vladimir Ritter and Dov Reichman in 1996 and is headquartered in Yavne, Israel.

Variance Economic Consulting Ltd. engages in the provision of financial, economic, and business consulting services. Its services include economic consulting for financial reporting purposes, project financing, and expert opinion. The company was founded by Ram Levy in 2002 and is headquartered in Tel Aviv, Israel.

Part of Clal Biotechnology Industries Ltd., Clal Life Sciences (CLS) LP is a venture capital fund.

I.B.I Israel Biomedical Innovations Ltd. provides surgical and medical solutions specifically for gynecology, urology and gastroenterology. The company was founded in 2004 and is headquartered in Haogen, Israel.

Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel.

PFC, Inc. manufactures boating designs and services. The company was founded in 1979 and is headquartered in Hartsville, SC.

Sage Healthcare Ltd. provides management consulting services to the healthcare industry. The firm's services include strategic analysis and development; mergers and acquisitions; business development, support, and planning; corporate partnering; licensing and venturing; technology and compound brokerage; valuations and value-enhancement planning; forecasting; risk assessment and due diligence; and commercial and technical assessment. The company was founded in 1995 and is headquartered in Great Shelford, GB.

Saguna Networks Ltd. provides mobile content delivery solutions. The firm offers Saguna Open-RAN product. It offers content optimization delivery system, a carrier grade system, providing content caching and acceleration designed to meet the demand of content over WiMAX(TM) networks. The company was founded by Lior Fite and Danny Frydman in 2008 and is headquartered in Yokneam, Israel.

Campus Bio Management Ltd. engages in the development of biopharmaceuticals and medical devices licensed from academic institutes for cancer and inflammatory diseases. The company was founded in May 2008 and is headquartered in Tel Aviv, Israel.

Amdocs (Israel) Ltd. provides information solutions to the communications industry worldwide. It offers customer care, billing, and order management systems for communications and Internet services providers; and business support systems for directory publishing companies. The company was founded in 1987 and is headquartered in Raanana, Israel.

Pi-Cardia Ltd. develops catheter for the treatment of aortic stenosis. Its technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the surrounding soft tissue. The company was founded by Eyal Kolka and Erez Golan in 2009 and is headquartered in Rehovot, Israel.

Van Leer Xenia Ventures (Van Leer Xenia Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Jerusalem, Israel.

Colospan Ltd. operates as a clinical stage and medical device company that develops a technology for colorectal surgery to prevent the profound clinical and economic pains associated with colorectal anastomotic leaks and diverting stomas. The company was founded by Boaz Assaf in December 2010 and is headquartered in Kfar Saba, Israel.

FDNA, Inc. develops phenotype applications. The private company is based in Boston, MA.

Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012.

Pyxis Diagnostics Ltd. was founded in 2019 and is based in Jerusalem, Israel. The Israeli company's mission is to identify patients who are likely to respond to immunotherapy and to discover new targets and drug combinations to treat those who do not. The company achieves this by leveraging their ability to delineate the immune-tumor-stroma communication networks.

Founded in 1950, Direct Table Foods Ltd. is a part of Tönnies Holding ApS & Co. KG and processes and supplies meat. The company is based in Bury St. Edmunds, UK.